ETP Nanomedicine and NANOMED2020: Towards a New Nanomedicine Horizon
Conference Recording May 27, 2014
About the Speaker
Mr Olivier Fontaine trained as a multidisciplinary engineer at Ecole Centrale de Lille (France) with a Nanomedicine MSc at Cranfield University (UK), Olivier Fontaine worked for one year at the secretariat of the European Technology Platform on Nanomedicine (ETPN, Germany) within the NANOMED2020 European project as an International Volunteer from Nanobiotix (France). He was notably in charge of mapping the nanomedicine actors and initiatives at the European level, along with contributing to novel communication tools and establishing the state-of-the art activities and needs in translational nanomedicine. Now Project Leader at Nanobiotix, he continues to take an active lead in the NANOMED2020 project and is devoted to the coordination with the ETPN and the elaboration of strategic documents. Abstract
The European Technology Platform on Nanomedicine (ETPN) is an initiative set-up in 2005 to define the strategic research priorities to be funded in the field, led by industry and officially recognized by the European Commission (EC) as part of the external advice and societal engagement needed to implement the coming Framework Program called Horizon 2020. The ETPN is addressing the application of nanotechnology to achieve breakthroughs in healthcare and conducted in the last year under the NANOMED2020 EU project several analyses, studies and interviews to map all actors in Nanomedicine in Europe and to define the needs for the successful translation of outstanding research into innovative products. As a result of this undertaking, the ETPN published last June a White Paper on “Nanomedicine Contribution to Horizon 2020”.